Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12, 2018 in Boston

Press release - No. 06 / 2018

Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12, 2018 in Boston

Copenhagen, March 5, 2018 - Britt Meelby Jensen, President and Chief Executive Officer (CEO) of Zealand Pharma, will present at the Cowen and Company 38^th Annual Health Care Conference in Boston, at the Boston Marriott Copley Place on Monday, March 12, 2018 at 2:50-3:20 pm (EST).

For further information, please contact:

Britt Meelby Jensen, President and Chief Executive Officer
Tel: +45 51 67 61 28, e-mail: bmj@zealandpharma.com
Mats Blom, Senior Vice President, Chief Financial Officer
Tel: +45 31 53 79 73, e-mail: mabl@zealandpharma.com

About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi and Boehringer Ingelheim, and a pipeline of internal product candidates focusing on specialty gastrointestinal and metabolic diseases.

Zealand is based in Copenhagen (Glostrup), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or follow Zealand on LinkedIn or Twitter @ZealandPharma.

Attachment:

http://www.globenewswire.com/NewsRoom/AttachmentNg/a784291b-565b-49e0-8e5f-8b78738d209e